The results showed that NFE2L3 expression was significantly positively correlated with MSI in STAD, KICH, and THYM, however NFE2L3 expression was negatively correlated with DLBC and CHOL (Figure 8A). This evidence concerns the gene NFE2L3 and gastric adenocarcinoma.